...
首页> 外文期刊>International braz j urol >lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
【24h】

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion

机译:lncRNA CCAT1促进膀胱癌细胞的增殖,迁移和侵袭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study the expression patterns of long noncoding RNA (lncRNA) colon cancer-associated transcript 1 (CCAT1) and the changes in cell proliferation, apoptosis, migration and invasion induced by silencing CCAT1 in bladder cancer cells. Materials and Methods: The expression levels of CCAT1 were determined using realtime quantitative polymerase chain reaction in cancerous tissues and paired normal tissues from 34 patients with bladder cancer. The relationship between clinical characteristics and CCAT1 expression was analyzed. And then we conducted cell experiments. Bladder urothelial carcinoma cell lines T24 and 5637 cells were transfected with CCAT1 small interfering RNA (siRNA) or scramble siRNA. Cell proliferation and apoptosis changes were determined using a Cell Counting Kit-8 (CCK-8) assay and a flow cytometry assay. Migration and invasion changes were measured using a wound healing assay and a trans-well assay. microRNAs (miRNAs) were predicted by Starbase 2.0, and their differential expression levels were studied. Results: CCAT1 was significantly upregulated in bladder cancer (P 0.05). CCAT1 upregulation was positively related to tumor stage (P = 0.004), tumor grade (P = 0.001) and tumor size (P = 0.042). Cell proliferation, migration and invasion were promoted by abnormally expressed CCAT1. miRNAs miR-181b-5p, miR-152-3p, miR-24-3p, miR-148a-3p and miR-490-3p were potentially related to the aforementioned functions of CCAT1. Conclusion: CCAT1 plays an oncogenic role in urothelial carcinoma of the bladder. In addition, CCAT1 may be a potential therapeutic target in this cancer.
机译:目的:研究长非编码RNA(lncRNA)结肠癌相关转录本1(CCAT1)的表达模式以及沉默CCAT1在膀胱癌细胞中诱导的细胞增殖,凋亡,迁移和侵袭的变化。材料与方法:采用实时定量聚合酶链反应法检测34例膀胱癌患者癌组织和配对正常组织中CCAT1的表达水平。分析了临床特征与CCAT1表达之间的关系。然后我们进行了细胞实验。用CCAT1小干扰RNA(siRNA)或加扰siRNA转染膀胱尿路上皮癌细胞系T24和5637细胞。使用细胞计数试剂盒8(CCK-8)测定和流式细胞术测定来确定细胞增殖和凋亡变化。使用伤口愈合测定法和跨孔测定法测量迁移和侵袭变化。通过Starbase 2.0预测microRNA(miRNA),并研究其差异表达水平。结果:膀胱癌中CCAT1显着上调(P <0.05)。 CCAT1上调与肿瘤分期(P = 0.004),肿瘤等级(P = 0.001)和肿瘤大小(P = 0.042)呈正相关。 CCAT1的异常表达促进了细胞的增殖,迁移和侵袭。 miRNA miR-181b-5p,miR-152-3p,miR-24-3p,miR-148a-3p和miR-490-3p可能与上述CCAT1功能有关。结论:CCAT1在膀胱尿路上皮癌中起着致癌作用。另外,CCAT1可能是该癌症的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号